Skip to main content
. 2016 Aug 10;104(3):663–670. doi: 10.3945/ajcn.116.137083

TABLE 3.

Unadjusted predictors of treatment failure1

Characteristic Unknown Overall (n = 182) Cholestasis resolved (n = 156) Treatment failure (n = 26) P
Males 0 104 (57) 88 (56) 16 (62) 0.62
Caucasians 0 126 (69) 111 (71) 15 (58) 0.17
Hispanics 2 35 (19) 31 (20) 4 (15) 0.57
Birth gestational age, wk 9 32 (26, 36) 32 (26, 36) 31 (26, 34) 0.30
Birth weight, g 17 1475 (800, 2305) 1608 (815, 2438) 1020 (737, 1776) 0.03
Extremely low birth weight (<1 kg) 17 57 (35) 47 (33) 10 (48) 0.18
Birth length, cm 80 41.7 (34.0, 46.5) 42.0 (34.5, 47.0) 36.2 (32.0, 41.5) 0.05
Age at PN start, d 6 1.0 (0.0, 2.0) 1.0 (0.0, 2.0) 1.0 (0.0, 2.0) 0.59
Age at FO start, wk 7 12.7 (7.7, 24.9) 11.7 (7.3, 21.4) 20.4 (9.9, 38.6) 0.02
≤14 d FO therapy 3 6 (3) 4 (3) 2 (8) 0.18
Ever exclusive enteral feeding 2 33 (18) 27 (17) 6 (24) 0.41
Any prior operations 1 173 (96) 149 (96) 24 (96) 1.00
Stoma2 3 88 (49) 77 (50) 11 (44) 0.58
 Duodenostomy 3 9 (5) 9 (6) 0 (0) 0.36
 Jejunostomy 3 42 (23) 38 (25) 4 (16) 0.34
 Ileostomy 3 37 (21) 31 (20) 6 (24) 0.66
 Colostomy 3 4 (2) 3 (2) 1 (4) 0.46
1

Values are n (%) or medians (IQRs) unless otherwise noted. P values are from Pearson’s chi-square or Fisher’s exact tests if categorical and Wilcoxon’s rank-sum test otherwise. FO, fish oil; PN, parenteral nutrition.

2

Stoma location, if present, at time of FO therapy initiation (most proximal if multiple).